Investing.com - Financial Markets Worldwide

Chunghwa Chemical Synthesis & Biotech Co Ltd (1762)

Taiwan
Currency in TWD
27.75
+0.15(+0.54%)
Closed·
1762 Scorecard
Full Analysis
High shareholder yield
1762 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
27.5028.00
52 wk Range
23.5045.65
Key Statistics
Edit
Bid/Ask
64.10 / 64.20
Prev. Close
30.4
Open
27.7
Day's Range
27.5-28
52 wk Range
23.5-45.65
Volume
127.61K
Average Volume (3m)
68.02K
1-Year Change
-39.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1762 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
28.00
Upside
+0.90%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
Trading at a low Price / Book multiple
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Chunghwa Chemical Synthesis & Biotech Co Ltd Company Profile

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is based in New Taipei City, Taiwan.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
198
Market
Taiwan

Compare 1762 to Peers and Sector

Metrics to compare
1762
Peers
Sector
Relationship
P/E Ratio
−30.9x18.5x−0.6x
PEG Ratio
0.150.130.00
Price/Book
0.7x3.0x2.6x
Price / LTM Sales
1.8x3.1x3.3x
Upside (Analyst Target)
1.4%0.6%39.1%
Fair Value Upside
Unlock21.4%5.4%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 28.00
(+0.90% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1.53%
Dividend Yield
0.68%
Industry Median 2.61%
Annualised payout
0.19
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-1.21 / --
Revenue / Forecast
344.00M / --
EPS Revisions
a
a
Unlock
Last 90 days

1762 Income Statement

FAQ

What Stock Exchange Does CCSB Trade On?

CCSB is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for CCSB?

The stock symbol for CCSB is "1762."

What Is the CCSB Market Cap?

As of today, CCSB market cap is 2.12B.

What Is CCSB's Earnings Per Share (TTM)?

The CCSB EPS (TTM) is -1.53.

When Is the Next CCSB Earnings Date?

CCSB will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is 1762 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CCSB Stock Split?

CCSB has split 0 times.

How Many Employees Does CCSB Have?

CCSB has 198 employees.

What is the current trading status of CCSB (1762)?

As of 29 Aug 2025, CCSB (1762) is trading at a price of 27.75, with a previous close of 30.40. The stock has fluctuated within a day range of 27.50 to 28.00, while its 52-week range spans from 23.50 to 45.65.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.